Finerenone prevented new-onset atrial fibrillation or flutter in patients with chronic kidney disease and type 2 diabetes or ...

Some kidney conditions are due to genetic factors or pregnancy-related complications and daily-life preventive measures may ...

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

A Diabetes, Heart Failure, and Kidney Disease Medication Is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes Feb. 11, 2025 — Over 1,000 genes may serve as possible ...

Employment among patients with kidney disease remains low even after dialysis or a transplant, with physical and social ...

Your kidneys are crucial in maintaining health by filtering waste, balancing body fluids, and regulating blood pressure.

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

Medscape News UK, February 27, 2025 Bone-Derived Hormone Predicts Diabetic Kidney Disease Risk Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for ...